Drug
Inclocibart clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2024
How studies write it
Studies that test it under each name
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses inclocibart is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein ThrombosisCompletedPhase 2BayerNCT06149520Written as BAY3018250
- A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese ParticipantsCompletedPhase 1BayerNCT06619483Written as BAY3018250 Dose 1
- A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 YearsCompletedPhase 1BayerNCT06562985Written as BAY3018250 Dose 1
Codes
What other systems call inclocibart · ClinicalTrials.gg INT015386
- UNII (FDA) 738QN3J7K8INCLOCIBARTOne source FDA
- NCI Thesaurus C224747InclocibartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 738QN3J7K8 | INCLOCIBART | One source FDA |
| NCI Thesaurus | C224747 | Inclocibart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.